Cerapedics Completes First U.S. Patient Treatment with New Bone Graft
Cerapedics Inc. successfully treated the first U.S. patient using its newly approved bone graft designed to accelerate lumbar fusion. This marks a significant milestone following the approval from the U.S. Food and Drug Administration (FDA) for the PearlMatrix P-15 Peptide Enhanced Bone Graft. The procedure was carried out at AdventHealth Avista in Louisville, Colo., by…more










